Oncology & Cancer
Response to gene-targeted drugs depends on cancer type
Cancers with the same genetic weaknesses respond differently to targeted drugs depending on the tumour type of the patient, new research reveals.
Jul 2, 2019
0
0
Molecular Cancer Therapeutics
Oncology & Cancer
How human genetic data is helping dogs fight cancer
Some of what we learn through the compassionate treatment of dogs with cancer goes on to help human patients. Now a study by researchers at University of Colorado Cancer Center and Colorado State University Flint Animal Cancer ...
Jun 25, 2019
0
0
Medical research
Gold nanoparticle delivery of microRNA impairs metastasis in triple-negative breast cancer
Weill Cornell Medicine researchers have shown that giving mice with triple-negative breast cancer therapeutic microRNA (miRNA) in a protective gold nanoparticle results in significantly less spreading of cancer to the lung. ...
Apr 12, 2019
0
5
Oncology & Cancer
New drug combination could be more effective against melanoma
A class of cancer drugs called protein kinase inhibitors is one of the most effective treatments for melanoma. However, in many cases, tumors eventually become resistant to the drugs and cause a relapse in the patient.
Dec 3, 2018
0
221
Oncology & Cancer
Experimental drug combined with radiation kills brain tumors in pre-clinical studies
A new study led by scientists at VCU Massey Cancer Center has shown that an experimental drug known as AZ32 selectively sensitizes brain tumors to radiation and significantly extends the survival of mouse models with human ...
Jun 27, 2018
0
253
Oncology & Cancer
Study reports possible novel method for stopping untreatable pediatric brain cancers
Researchers used an experimental molecular therapy in preclinical laboratory tests to effectively treat several types of deadly pediatric brain cancer and now propose advancing the treatment to clinical testing in children.
Apr 17, 2018
0
8
Oncology & Cancer
New class of drugs could help tackle treatment-resistant cancers
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies.
Apr 10, 2018
0
142
Oncology & Cancer
Researchers find a pathway that leads to resistance of aggressive brain tumor treatment
Glioblastoma multiforme is one of the most common and deadly brain tumors. Despite the initial responsiveness to state-of-the-art therapies, tumors virtually always become resistant and eventually recur. Researchers at Dartmouth's ...
Feb 16, 2018
0
2
Oncology & Cancer
Researchers modify common flu virus to attack pancreatic cancer
A modified flu virus has now been used in experiments to successfully inhibit the growth of pancreatic cancer, according to an early study by Queen Mary University of London.
Jan 24, 2018
0
102
Oncology & Cancer
Metformin could one day be used to treat malignant tumors
A*STAR researchers have provided strong evidence, using patient tumor grafts, that metformin, a common diabetes drug, might help fight colorectal cancer in humans.
Jan 16, 2018
0
40
